查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
藥物輸送設備市場：按給藥途徑、按應用、按最終用戶、按地區 - 規模、份額、前景和機會分析，2022-2028 年
市場調查報告書
商品編碼
1181741

藥物輸送設備市場：按給藥途徑、按應用、按最終用戶、按地區 - 規模、份額、前景和機會分析，2022-2028 年

Drug Delivery Device Market, By Route of Administration, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

藥物輸送裝置被定義為一種用於輸送治療物質的裝置，該治療物質到達其作用部位而不到達非靶細胞、器官和/或組織。使其成為可能。 這些裝置用作一種或多種醫療程序的一部分，以通過特定的給藥途徑輸送藥物或治療劑。

市場動態

慢性/非傳染性疾病負擔的增加、技術先進的藥物輸送設備的日益普及、蓬勃發展的生物製品市場以及 COVID-19 的爆發將推動全球藥物輸送設備市場的增長，預計這將成為主要因素。

例如，2022 年 9 月，Corium 宣布 ADLARITY（多奈□齊的透皮系統）現在可在美國用於治療輕度、中度和重度阿爾茨海默病患者的處方。 此外，我們於 2022 年 2 月推出了用於注射 Taxilo (lanadelumab furio) 的單劑量預充式註射器，用於預防成人和 12 歲及以上兒童的遺傳性血管性水腫 (HAE) 發作。它已獲得美國食品和藥物管理局的批准。藥物管理局 (USFDA) 認證，現已在美國上市銷售。

這項研究的主要特點

  • 本報告對全球給藥設備市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR%)。 .
  • 它還闡明了各個細分市場的潛在創收機會，並概述了針對該市場的一系列有吸引力的投資建議。
  • 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
  • 全球給藥設備市場主要參與者的概況基於以下參數，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
  • 本研究涵蓋的主要公司包括輝瑞公司、諾華公司 (Sandoz)、F. Hoffmann-La Roche Ltd.、強生公司和拜耳公司等。
  • 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
  • 《藥物輸送設備全球市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球給藥設備市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 按給藥途徑劃分的市場概況
    • 市場概況：按應用分類
    • 市場概況：按最終用戶分類
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

  • 市場動態
    • 慢性病和非傳染性疾病的負擔增加
    • 產品召回和針刺傷風險
    • 生物製劑市場的快速增長
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/批准
  • 害蟲分析
  • 對 PORTER 的分析
  • 合併/收購場景

第 4 章全球藥物輸送設備市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 的流行病學特徵
  • 供應方和需求方分析
  • 經濟影響

第 5 章全球給藥裝置市場：按給藥途徑，2017-2028

  • 注射
  • 局部管理
  • 眼科
  • 其他給藥途徑

第 6 章全球藥物輸送設備應用市場，2017-2028

  • 癌症
  • 心髒病學
  • 糖尿病
  • 感染
  • 其他應用領域

第 7 章全球給藥設備市場：按最終用戶分類，2017-2028

  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 8 章按地區分列的全球給藥設備市場，2017-2028

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第9章競爭格局

  • Pfizer Inc.
  • Novartis AG（Sandoz）
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Bayer AG

第 10 章

  • 調查方法介紹
  • 關於出版商
簡介目錄
Product Code: CMI5419

A drug delivery device is defined as the device used to deliver a therapeutic substance and enables a therapeutic substance to reach its site of action without reaching non-target cells, organs, and/or tissues. These devices are used as part of one or more medical treatments to delivery a drug or a therapeutic agent via a specific route of administration.

Market Dynamics:

Increasing burden of chronic/non-communicable diseases, increasing adoption of technologically advanced drug delivery devices, rapid growth in the biologics market, and the outbreak of COVID-19 are major factors expected to drive growth of the global drug delivery device market.

For instance, in September 2022, Corium, Inc. announced that ADLARITY (donepezil transdermal system) is now available for prescription in the United States for the treatment of people with mild, moderate, or severe dementia of Alzheimer's type. Moreover, in February 2022, Takeda received the U.S. Food and Drug Administration (USFDA) approval for TAKHZYRO (lanadelumab-flyo) injection single-dose prefilled syringe, which is used to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.

Key features of the study:

  • This report provides in-depth analysis of the global drug delivery device market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global drug delivery device market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Novartis AG (Sandoz), F. Hoffmann-La Roche Ltd., Johnson & Johnson, and Bayer AG, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market.

Detailed Segmentation:

  • Global Drug Delivery Device Market, By Route of Administration:
    • Injectable
    • Topical
    • Ocular
    • Other Routes of Administration
  • Global Drug Delivery Device Market, By Application:
    • Cancer
    • Cardiovascular
    • Diabetes
    • Infectious Diseases
    • Other Applications
  • Global Drug Delivery Device Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Other End Users
  • Global Drug Delivery Device Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Pfizer Inc.
    • Novartis AG (Sandoz)
    • F. Hoffmann-La Roche Ltd.
    • Johnson & Johnson
    • Bayer AG

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing burden of chronic/non-communicable diseases
    • Product recalls and risk of needlestick injuries
    • Rapid growth in the biologics market
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Drug Delivery Device Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Delivery Device Market, By Route of Administration, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Ocular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Routes of Administration
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Drug Delivery Device Market, By Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Drug Delivery Device Market, By End User, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other End Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Drug Delivery Device Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG (Sandoz)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us